Fact-checked by Grok 2 weeks ago

Pregnancy tests using animals

Pregnancy tests using animals, also known as biological assays for detecting (hCG) in , were a cornerstone of prenatal diagnostics from the early until the , relying on the physiological responses of various species to injected samples from potentially pregnant individuals. These tests emerged following the discovery of hCG as a pregnancy-specific hormone in the 1920s, with the first widely adopted method being the Aschheim-Zondek test developed in 1927 by Selmar Aschheim and Bernhard Zondek, which involved injecting into immature female mice and examining ovarian changes such as the formation of corpora lutea after approximately 100 hours to confirm pregnancy, achieving accuracies of 82.5% to 99.5%. In 1931, Maurice Harold Friedman introduced the using female rabbits, where a single intravenous injection of induced detectable within 48 hours via surgical examination or , offering similar high accuracy and becoming a standard in clinical laboratories due to its reliability. Further innovations in the 1940s expanded options with less invasive procedures; the Hogben test, devised by , utilized the (Xenopus laevis), injecting urine subcutaneously and observing for egg deposition within 2 to 12 hours as a positive indicator, with the advantage of reusing the frogs without sacrifice. Similarly, the 1947 Galli-Mainini test employed male South American toads (Bufo arenarum), where urine injection into the lymphatic sac prompted spermiation (sperm release) within 3 to 5 hours, detectable by microscopic examination of urine, minimizing animal harm and allowing rapid results. By the mid-20th century, these animal-based assays were performed in specialized labs worldwide, processing thousands of tests annually and playing a pivotal role in , though they raised ethical concerns over due to frequent sacrifices in methods like the Aschheim-Zondek and tests. Their decline began in the with the advent of immunological and chemical detection kits, which eliminated the need for live animals and enabled at-home testing by the 1970s, rendering bioassays obsolete by the 1980s.

Background

Historical Context

Before the development of reliable biological assays in the early , attempts to diagnose relied on rudimentary and often unscientific methods. In around 1350 BCE, a common practice involved urinating on and seeds; if the seeds sprouted, it was interpreted as a positive sign of , though this method lacked scientific validation and had low accuracy. Similar non-empirical approaches persisted through the and into the , including visual inspections of for color or and provocative tests like administering sweet drinks to observe reactions. By the early 1900s, chemical-based efforts emerged, such as Emil Abderhalden's 1912 serum reaction test, which aimed to detect pregnancy-specific proteins in through enzymatic breakdown but proved unreliable due to frequent false positives and lack of specificity. The breakthrough in pregnancy testing came in the 1920s amid growing understanding of reproductive hormones. In 1927, German researchers Selmar Aschheim and Bernhard Zondek discovered that urine from pregnant women contained a substance—initially termed the anterior pituitary-like hormone, later identified as (hCG)—that induced specific physiological responses in animals, laying the foundation for the first dependable diagnostic method. This insight shifted pregnancy detection from speculative techniques to biologically grounded assays, enabling the introduction of the Aschheim-Zondek test in 1927, which used immature female mice to detect hCG. Subsequent innovations expanded the use of animal models. In 1931, Maurice Friedman developed a variant using rabbits, which offered faster results; this was followed by Lancelot Hogben's 1930 test employing the ( laevis) for its sensitivity to hCG-induced ovulation. By 1947, Carlos Galli-Mainini introduced a test with male South American toads, which responded by producing sperm, further simplifying the process. These methods reached their zenith in the and , with millions of tests conducted annually worldwide across laboratories, achieving accuracies of 82.5% to 99.5% and becoming a standard tool in clinical practice. The advent of these animal-based tests had profound social implications by allowing early pregnancy confirmation as soon as one to two weeks after a missed period, far surpassing the previous reliance on delayed physical symptoms or invasive pelvic examinations. This timeliness facilitated better planning, reduced uncertainty for women, and supported broader access to reproductive services during a period when such diagnostics were transformative for family and medical decision-making.

Scientific Foundation

Human chorionic gonadotropin (hCG) is a produced by cells of the shortly after implantation of the fertilized , serving as a key marker of early . Its primary role involves maintaining the to sustain progesterone production, thereby supporting the uterine lining and preventing . Structurally, hCG comprises two subunits: an alpha subunit shared with other hormones like (LH) and (FSH), and a subunit unique to hCG that enables specific immunological and biological detection. In , serum hCG levels rise rapidly, doubling approximately every 48 hours in the first weeks and peaking around 8-10 weeks of at levels up to 100,000-200,000 IU/L before gradually declining. The biological mechanism underlying animal-based pregnancy tests relies on hCG's ability to mimic LH, binding to the same receptors (LHCGR) on gonadal cells across various species. This structural —particularly in the beta subunit, with about 80-85% similarity between hCG and LH—allows exogenous hCG from human urine to stimulate reproductive responses in injected animals, such as maturation, in females, or in males. In practice, this induces observable changes like corpora hemorrhagica formation or egg release, confirming hCG presence. Sensitivity to hCG varies by species due to differences in receptor affinity and metabolic clearance; mammals such as and rabbits typically respond to lower doses (around 1-5 ), while amphibians require higher thresholds (up to 200 or more) for equivalent responses. Animals were chosen for these tests based on their pronounced and reliable gonadal responses to hCG, which amplify subtle hormonal signals into macroscopic endpoints. Immature female , for instance, develop ovarian hyperemia and follicle enlargement in response to low hCG doses, while mature female rabbits exhibit rapid within 24-48 hours, facilitating quicker assessments. Amphibians like the ( laevis) release eggs within 12 hours of injection, offering a non-lethal, reusable model despite lower . These tests could reliably detect urinary hCG concentrations as low as 5-10 /L, corresponding to early stages around implantation. To standardize results and enhance detectability, samples were often concentrated through to reduce and increase hCG , or administered in fixed injection volumes (e.g., 0.5-5 mL subcutaneously or intravenously) to control dosage exposure. However, false positives could arise from ectopic hCG production unrelated to , such as in gestational trophoblastic diseases or tumors, where elevated levels mimic signals.

Aschheim-Zondek Test

Procedure

The Aschheim-Zondek uses immature female mice, typically 3-5 weeks old and weighing 6-10 grams, as test subjects, with 3-5 mice required per to ensure reliability. To perform the , a urine sample from the is first tested for acidity and adjusted to a pH if necessary, with 1-2 drops of tricresol added as a and the sample filtered if cloudy. Approximately 0.2-0.5 mL of is then injected subcutaneously into each mouse, administered twice daily for three consecutive days at different body sites, followed by a rest day on the fourth day. After approximately 100 hours from the first injection (totaling about 5 days), the mice are euthanized humanely, dissected, and their ovaries examined macroscopically and microscopically for changes indicative of (hCG) exposure. A positive result is indicated by ovarian hyperemia (enlargement to 2-3 times normal size with red hemorrhagic spots), formation of corpora lutea, or mature follicles; the uterus may also show enlargement or specific vaginal cell changes (e.g., "Schollenstadium"). Absence of these ovarian changes, potentially with only uterine enlargement, indicates a negative result, though repeat testing is recommended if heat signs are present. The test was developed in by researchers Selmar Aschheim and Bernhard Zondek and achieved approximately 98% accuracy in early clinical use.

Advantages and Limitations

The Aschheim-Zondek test provided significant advantages as one of the first reliable biological assays for , offering high specificity for detecting hCG produced by placental , with reported accuracy rates of 98-98.9% based on thousands of evaluations. It enabled early from the fourth week of and was also useful for identifying conditions like , hydatidiform mole, chorioepithelioma, incomplete abortion, and certain testicular tumors, making it a foundational tool in and during the 1920s-1950s. However, the test had key limitations that limited its practicality. It was time-intensive, requiring up to 5 days for results, which delayed clinical decisions compared to later methods. The procedure involved euthanizing multiple mice per test, raising early ethical concerns about and increasing operational costs due to the need for a steady supply of immature animals. False negatives (about 1-2%) could occur with very early pregnancies or interfering substances like certain medications (e.g., sleeping pills or painkillers), while false positives were rare but possible in non-pregnancy hCG-producing conditions. The complexity demanded skilled technicians for injections and dissections, restricting it to specialized laboratories, and it became obsolete by the with the rise of non-animal immunological tests.

Friedman Test

Procedure

The Friedman test utilizes sexually mature, non-pregnant female rabbits, typically post-partum or virgin adults weighing 2-3 kg, as test subjects. To perform the test, a sample of the woman's morning (concentrated, with fluid intake restricted to 6 oz from 4 p.m. the previous day) is collected, refrigerated, filtered to remove precipitates, acidified if alkaline, and warmed to body temperature. Approximately 4-10 mL of prepared is injected intravenously into the rabbit's marginal using a 23-gauge needle, often under light . A single injection or up to three daily injections over two days may be used, depending on the variant. The rabbit is then maintained under observation for 24-48 hours post-injection. At the end of this period, the animal is anesthetized with ether, and the ovaries are surgically exposed or examined via autopsy to check for physiological changes. A positive result is indicated by the presence of ruptured or hemorrhagic ovarian follicles, fresh corpora lutea, or corpora hemorrhagica in the ovaries, which are triggered by (hCG) in pregnant urine stimulating ovulation. The degree of reaction may be graded from 1+ to 4+ based on the extent of ovarian and uterine changes, such as congestion and swelling of the uterine horns. Absence of these changes indicates a negative result. Due to the need for invasive examination, the rabbit is typically sacrificed after the procedure. Developed in 1930 by American physiologist Maurice Harold Friedman and Maxwell Edward Lapham at the , this test requires surgical tools, anesthesia, and microscopic or gross examination capabilities, and achieved high accuracy rates of 95-99% in clinical use for detecting from the fourth week onward.

Advantages and Limitations

The Friedman test provided significant advantages over earlier methods like the Aschheim-Zondek test, primarily through its faster results and simplified protocol. Unlike the multi-day subcutaneous injections and extended observation (up to 100 hours) required for the Aschheim-Zondek mouse assay, the Friedman test delivered results within 24-48 hours via a single or few intravenous injections, facilitating quicker diagnoses in clinical settings. It demonstrated high sensitivity to hCG, reliably detecting pregnancies as early as 7-10 days after a missed period, with reported accuracy between 95% and 99% in large-scale evaluations during the 1930s-1950s. The test's specificity allowed differentiation of pregnancy from conditions like hydatidiform mole or chorionepithelioma, where excessive gonadotropins produced similar ovarian responses. Its adoption in laboratories worldwide made it a standard for prenatal confirmation until the 1960s, processing thousands of samples annually. However, the test had substantial limitations, most notably its ethical and practical drawbacks due to . Each test required killing the rabbit via surgical exploration or to inspect the ovaries, leading to the consumption of tens of thousands of s yearly and raising concerns even in its era. The demanded skilled personnel for intravenous injection and surgical , increasing operational complexity and cost compared to later non-invasive assays. False negatives could occur with dilute or improperly handled (e.g., if not concentrated or contaminated), while false positives were possible from non-pregnancy sources of gonadotropins, such as pituitary tumors, , or certain urinary toxins that stressed the animal. was lower in very early (before hCG exceeds 500 /L) or late stages when hormone levels fluctuate. Additionally, the test's reliance on live s posed logistical challenges, including breeding, housing, and disposal, limiting its use in resource-poor areas. By the , less invasive alternatives like the Hogben and Galli-Mainini tests began supplanting it, highlighting its humane and efficiency shortcomings.

Hogben Test

Procedure

The Hogben test utilizes sexually mature female African clawed frogs (Xenopus laevis), typically 8-12 cm in length, as the test subjects. To perform the test, 0.5-1 mL of the woman's is injected subcutaneously into the dorsal lymph sac of the frog using a fine needle. The frog is then placed in a container of to maintain hydration and left undisturbed for 2-12 hours. Following the , the water is examined for the presence of eggs. A positive result is indicated by the deposition of eggs, triggered by (hCG) in pregnant urine inducing ; absence of eggs indicates a negative result. The frog is reusable for multiple tests after a recovery period of several days. Developed in the 1940s by British zoologist , this method requires basic equipment such as a for injection and a container for observation, and demonstrates high accuracy, with reported rates of 93-99% in clinical use.

Advantages and Limitations

The Hogben test offered several advantages over earlier animal-based pregnancy diagnostics, particularly in its non-lethal nature and efficiency. Results could be obtained within 2-12 hours, faster than the Aschheim-Zondek test's 100 hours but comparable to the test's 48 hours, allowing for timely clinical decisions. Unlike mammalian tests that required sacrificing the animals for ovarian examination, the Hogben test allowed reuse of the frogs without harm, reducing ethical concerns, costs, and logistical needs for constant animal supply. The use of Xenopus laevis, which could be maintained in aquaria, made it practical for laboratories worldwide, and its specificity for hCG provided accuracy rates of 93-99% in studies, effective for detecting pregnancies from the second week onward when hCG exceeds 100 IU/L. However, the test had limitations that affected its reliability and practicality. It required specialized maintenance of live frogs, including controlled environments to prevent disease or , which could vary results if animals were unhealthy. False positives arose from cross-reactivity with (LH) in non-pregnant urine, such as during or in conditions like , leading to specificity issues in 3-7% of cases. Sensitivity was lower in very early (before 10-14 days post-missed period), with detection rates as low as 12% in the first week rising to 93% by the third. Operator interpretation of egg presence was subjective without standardization, and the need for fresh urine samples limited remote testing. By modern standards, the use of animals raises significant ethical concerns regarding and potential from repeated injections. Historically, the test was widely adopted from the to the in , , and , where was readily available, processing thousands of samples annually in specialized labs and contributing to accessible before immunological tests supplanted it.

Galli-Mainini Test

Procedure

The Galli-Mainini test utilizes adult male frogs, such as , or toads, such as , measuring 5-10 cm in length as the test subjects. Originally developed using the South American toad , it was adapted to species like the North American frog . To perform the test, a small volume of the woman's urine is injected subcutaneously into the dorsal lymph sac of the animal using a fine needle. The frog or toad is then placed in a moist container to maintain hydration and left undisturbed for 2-5 hours. Following the incubation period, a urine sample is collected from the amphibian by gentle bladder expression or via catheterization to avoid contamination. The sample is immediately examined under a light microscope at low magnification for the presence of spermatozoa, particularly motile forms in the sediment. A positive result is confirmed by the observation of in the , triggered by (hCG) in pregnant inducing spermiation; absence of indicates a negative result. The test animal is reusable for multiple assays after a recovery period. Developed in 1947 by Argentine endocrinologist Carlos Galli-Mainini, this method requires only basic equipment, such as a for injection and a for observation, and demonstrates approximately 96% accuracy in detecting early .

Advantages and Limitations

The Galli-Mainini test offered several key advantages over prior animal-based pregnancy diagnostics, primarily due to its rapid turnaround and minimal invasiveness to the test animals. Results could be obtained within 2 to 5 hours of injection, significantly faster than the multi-day waits required for tests like the Aschheim-Zondek or methods, enabling quicker clinical decision-making. Unlike those earlier assays, which often necessitated killing the animals to inspect ovarian changes, the Galli-Mainini test required no sacrifice; male amphibians could be reused multiple times after emission, thereby reducing ethical concerns and operational costs associated with animal procurement. The procedure utilized locally abundant , such as the South American toad Bufo arenarum in the or the common European toad bufo, making it accessible without reliance on imported or scarce animals like rabbits or mice. Its low cost further enhanced its practicality in resource-limited settings. The test demonstrated high specificity, with accuracy rates reported between 95% and 97% in clinical evaluations, particularly for detecting sufficient hCG levels typical in early , though it was less reliable for very early detection when hCG concentrations are low. Despite these strengths, the Galli-Mainini test had notable limitations that constrained its reliability and broad adoption. Accurate interpretation demanded microscopic examination to confirm presence in , requiring trained personnel and potentially introducing operator variability, unlike simpler observational methods in some alternatives. varied by , with toads generally more responsive than frogs, leading to inconsistent results depending on local availability— outperformed in responsiveness to hCG. False positives occurred due to with (LH) in non-pregnant , such as during menstrual cycles or certain medical conditions, reducing overall to around 84–97% in comparative studies against the . The was also less effective for early pregnancy detection before the fourth week. Historically, the test gained popularity in and during the , where it was routinely performed in clinics and hospitals, with over 1,500 tests conducted at a single laboratory by early 1950 alone, reflecting its integration into routine gynecological practice. To mitigate frog shortages in regions where Rana species were preferred or unavailable, variants adapted the protocol for toads, leveraging their higher sensitivity and local prevalence to maintain supply without compromising efficacy. The reusability of animals slightly alleviated ethical burdens compared to lethal tests, though modern views critique the practice as inhumane.

Decline and Legacy

Replacement by Immunological Tests

In the early 1960s, the development of immunological assays marked a pivotal shift away from animal-based pregnancy tests, enabling direct detection of (hCG), the key pregnancy hormone, through antibody-antigen interactions without requiring live animals. Swedish researchers Leif Wide and Carl A. Gemzell introduced the first such test in 1960, utilizing hemagglutination inhibition, where hCG in urine samples prevented red blood cells coated with anti-hCG antibodies from clumping, providing results in a few hours with an analytical sensitivity of approximately 500 IU/L. This innovation, published in Acta Endocrinologica, laid the foundation for non-biological methods by leveraging purified hCG and rabbit-derived antibodies, achieving accuracy comparable to animal bioassays but eliminating the need for animal sacrifice. Subsequent advancements in the mid-1960s accelerated the transition. By 1967, latex agglutination tests emerged as a simpler variant, employing latex particles coated with anti-hCG antibodies that agglutinated in the presence of hCG-free urine, yielding results in under 2 minutes and suitable for clinical settings. In the 1970s, the , developed by Peter Perlmann and Eva Engvall around 1971, further refined detection by using enzyme-labeled antibodies to produce a color change proportional to hCG concentration, offering improved sensitivities compared to earlier assays. The discovery of monoclonal antibodies by Georges Köhler and in 1975 enhanced these assays' specificity and reproducibility, as uniform antibodies reduced variability inherent in polyclonal sources. These immunological methods rapidly obsoleted animal tests due to their superior practicality and performance. Unlike animal bioassays, which required days for observation and involved ethical and logistical burdens, immunological tests delivered results in minutes, became more affordable (with home kits costing around $10 by the late ), boasted high accuracy for detecting hCG at clinically relevant levels, and scaled easily for point-of-care or home use without specialized facilities. Animal-based tests, such as the Friedman rabbit assay, had peaked in usage during the 1950s, with widespread adoption in laboratories across the and , but their demand declined sharply post-1960 as immunological alternatives proliferated. By the , most clinical settings had phased out animal methods, though limited commercial use persisted into the in some regions with slower adoption of new technologies. The transition profoundly impacted pregnancy diagnostics by reducing reliance on laboratory infrastructure and empowering individuals with immediate, private testing. The 1971 launch of Predictor, the first over-the-counter home in the UK, exemplified this shift, using latex agglutination inhibition to detect hCG in within 2 hours, thereby enhancing and for users worldwide. This evolution not only democratized early pregnancy confirmation but also set the stage for modern rapid diagnostics.

Ethical and Environmental Impacts

The use of animals in tests raised significant ethical concerns, particularly regarding the routine sacrifice of mammals and the stress imposed on amphibians. In the , female rabbits were injected with urine and subsequently killed for ovarian examination, resulting in the deaths of tens of thousands of rabbits annually across diagnostic stations worldwide during the mid-20th century. This practice exemplified a violation of the 3Rs principles—, , and refinement—introduced in , as it relied on lethal procedures without alternatives, used multiple animals per test, and caused unnecessary suffering through injections and dissection without adequate analgesia. Early activism in the highlighted these issues, with protests against contributing to broader calls for humane reforms in practices, though specific demonstrations targeted at pregnancy tests were limited. Animal welfare challenges were pronounced in both mammalian and tests. Rabbits endured pain from intravenous or intravenous injections, followed by surgical , often under , a method later deemed inhumane due to its irritant effects and potential for respiratory distress. In the Hogben and Galli-Mainini tests, female laevis or pipiens frogs experienced physical stress from injections into the dorsal sac, manifesting as muscle contractions and temporary discomfort, despite the animals' reusability every 2–3 months. These procedures contravened refinement by failing to minimize harm, prompting ethical debates on the moral cost of using sentient vertebrates for routine diagnostics. Environmentally, the mass importation of for testing from 1940 to the 1970s—exceeding 400,000 individuals from —facilitated the global spread of the chytrid fungus Batrachochytrium dendrobatidis (). Trade routes introduced infected frogs to new regions, with Bd detected in U.S. populations as early as 1961, contributing to outbreaks that have driven the decline of over 500 species worldwide, including at least 90 extinctions. A 2013 study confirmed this link by analyzing preserved Xenopus specimens, revealing Bd prevalence dating back to the 1930s in n exports used for pregnancy assays. Intensive collection also disrupted native habitats in , exacerbating local pressures through overharvesting and ecosystem alteration. The legacy of these tests accelerated ethical reforms, influencing the 1966 U.S. Animal Welfare Act, which mandated standards for laboratory animals and indirectly addressed concerns amid rising public scrutiny. This period's controversies spurred the transition to immunological assays in the late 1960s, aligning with 3Rs advocacy by replacing animal use with in vitro methods. Today, they inform ongoing ethical discussions in , emphasizing the need to balance diagnostic utility with and ecological sustainability.

References

  1. [1]
    From Cereal Grains to Immunochemistry—What Role Have ... - NIH
    Aug 31, 2023 · Until the 1960s, pregnancy tests were mainly biological methods involving laboratory animals, mainly mice, rabbits, and a specific species of ...
  2. [2]
    [Laboratory diagnosis of pregnancy begins: Abderhalden's test]
    Among some tests proposed, the one developed in 1912 by a Swiss pioneer in clinical biochemistry, Emil Abderhalden, earned greatest response. Unlike other ...
  3. [3]
    The Aschheim-Zondek Test for Pregnancy
    Sep 12, 2010 · Remarkably, although Aschheim and Zondek developed the A-Z test in 1927, hCG itself was not discovered until the 1950s.Missing: based Hogben Galli- Mainini
  4. [4]
    History of Pregnancy Test | Encyclopedia MDPI
    Sep 11, 2023 · In 1947, Carlos Galli Mainini developed a pregnancy test using the male toad Bufoarenarum Hensel. This toad produced sperm in response to ...
  5. [5]
    The Birds and the Bees and the Frogs | Science History Institute
    Apr 15, 2025 · Given its superiority, by the 1940s, the Hogben pregnancy test was in high demand. ... The biggest labs carried out 10,000 tests per year.<|separator|>
  6. [6]
    Human Chorionic Gonadotropin - StatPearls - NCBI Bookshelf - NIH
    Apr 27, 2025 · Measuring hCG levels can help distinguish between normal and abnormal pregnancies and is also useful for monitoring after a pregnancy loss. In ...
  7. [7]
    Human Chorionic Gonadotropin - an overview | ScienceDirect Topics
    Human chorionic gonadotropin (hCG) is defined as a hormone that mimics luteinising hormone (LH) and is used clinically to stimulate ovulation, induce lactation, ...
  8. [8]
    Uphill battle: The saga of hCG research that led to a paradigm shift
    Because there is only one receptor, hCG and LH mimic each other's functions2. ... The LH is present in circulation in a cyclical manner during non-pregnancy ...
  9. [9]
    Animal research and pregnancy testing: a history
    Aug 30, 2023 · In the Aschheim-Zondek test, a urine sample was injected into a sexually immature female mouse. If hormones associated with pregnancy were ...Missing: Friedman Galli- Mainini
  10. [10]
    [PDF] EVALUATION OF PREGNANCY TESTS
    Galli Mainini Test employing frogs. 3. Galli Mainini Test employing male toads. 4. Richardson's chemical test. 5. Roland's cystological test.
  11. [11]
    MUST-KNOW URINALYSIS IN CLINICAL MICROSCOPY ... - Studocu
    Galli-Mainini. Male frogs, male toads. Subcutaneous injection. (+) ... 0.5mL/1 Urine sediment: 20μL (0 mL) -10 lpf -10 hpf -Reduced light RCF 1 x ...
  12. [12]
    Muvs - The Frog test - Museum of Contraception and Abortion
    As early as the 1940s, frogs were being used in pharmacies as 'pregnancy tests'. The pharmacist would inject a mature female frog with an early morning urine ...Missing: history based
  13. [13]
    The pregnancy test that changed everything - Uppsala University
    Apr 27, 2015 · Leif Wide's immunological pregnancy test was revolutionary. It was fast, reliable and simple to carry out. It was followed by a number of innovations.Missing: Galli- Mainini 1 million
  14. [14]
    Comparison of a New Latex Agglutination Pregnancy Test with an ...
    ... Pregnancy Test with an Established Latex Agglutination-Inhibition Test ... 01 January 1967. Article history. Received: 31 January 1966. Published: 01 January 1967.
  15. [15]
    An overview of ELISA: a review and update on best laboratory ...
    Feb 8, 2025 · By the early 1970s, several laboratories had adopted the ELISA test for diagnostic microbiology. By 1980, the ELISA method had been established ...
  16. [16]
    Accuracy of Home Pregnancy Tests and New Developments - PMC
    Eight days after conception, hCG can be detected in the maternal circulation 13; a concentration of approximately 10 mlU/ml is observed in serum between 9 and ...
  17. [17]
    Cane toads used for 1950s pregnancy testing by Australian ...
    Aug 5, 2021 · The practise was phased out when immunological testing was developed in the 1960s. In 1928, German researchers had discovered that when a woman ...
  18. [18]
    Predictor: The First Home Pregnancy Test | Journal of British Studies
    Jul 24, 2020 · This essay uses Predictor, the first home pregnancy test, to reexamine the doctor-patient relationship in Britain in the 1960s and 1970s.
  19. [19]
    How a Frog Became the First Mainstream Pregnancy Test
    May 4, 2017 · In the 1950s, if a woman wanted to know if she was pregnant, she needed to get her urine injected into a frog.Missing: based Galli- Mainini<|control11|><|separator|>
  20. [20]
    The 3Rs - NC3Rs
    The principles of the 3Rs (Replacement, Reduction and Refinement) were developed over 50 years ago providing a framework for performing more humane animal ...
  21. [21]
    (PDF) Isoflurane is a suitable alternative to ether for anesthetizing ...
    Aug 7, 2025 · Diethyl ether (ether) had been widely used in Japan for anesthesia, despite its explosive properties and toxicity to both humans and animals ...<|separator|>
  22. [22]
    The Xenopus Pregnancy Test - Duke University Press
    21 Pregnancy tests with animal models were gradually abandoned in the 1970s and 1980s as chemical tests became the norm in laboratories and later in the home.
  23. [23]
    (PDF) Historical perspectives on global exports and research of ...
    The African clawed frog, Xenopus laevis, was exported from its native region of southern Africa for use in pregnancy testing, and later for laboratory use as ...
  24. [24]
    Amphibian fungal panzootic causes catastrophic and ongoing loss ...
    We present a global, quantitative assessment of the amphibian chytridiomycosis panzootic, one of the most impactful examples of disease spread, and demonstrate ...
  25. [25]
    Prevalence of Batrachochytrium dendrobatidis in Xenopus Collected ...
    May 15, 2013 · Although Xenopus are no longer used for pregnancy testing, the impact of additional regulations restricting the trade of Xenopus would be ...
  26. [26]
    Animal Welfare Act | National Agricultural Library - USDA
    The Animal Welfare Act is a U.S. Federal law that regulates the treatment of animals in research, teaching, testing, and exhibition.
  27. [27]
    Ethical considerations regarding animal experimentation - PMC - NIH
    Due to the ethical issues surrounding the use of animals in experimentation, their use is declining in those research areas where alternative in vitro or in ...